Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Mosienko, V ^a,b   Bert, B ^c   Beis, D ^a,b   Matthes, S ^a,b   Fink, H ^c   Bader, M ^a   Alenina, N ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

aggression; anxiety; depression; serotonin; tryptophan hydroxylase

Indexed keywords

SEROTONIN; TRYPTOPHAN HYDROXYLASE 2; TPH2 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE;

AGGRESSION; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DEPRESSION; ELEVATED PLUS MAZE TEST; EXPERIMENTAL TEST; GENE EXPRESSION; HETEROZYGOSITY; MALE; MARBLE BURYING TEST; MAZE TEST; MOUSE; NONHUMAN; NOVELTY SUPPRESSED FEEDING TEST; PHENOTYPE; SEROTONIN BRAIN LEVEL; ANIMAL; BRAIN; C57BL MOUSE; FEMALE; GENETICS; HETEROZYGOTE DETECTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AGGRESSION; AGONISTIC BEHAVIOR; ANIMALS; ANXIETY; BRAIN; DEPRESSION; FEMALE; HETEROZYGOTE DETECTION; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 84861653106     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.44     Document Type: Article

References (84)

1. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003; 66: 1673-1680. (Pubitemid 37249312)
2. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003; 299: 76. (Pubitemid 36042402)
3. Gutknecht L,Waider J, Kraft S, Kriegebaum C, Holtmann B, Reif A et al. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm 2008; 115: 1127-1132.
4. Patel PD, Pontrello C, Burke S. Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry 2004; 55: 428-433. (Pubitemid 38199994)
5. Neal KB, Parry LJ, Bornstein JC. Strain-specific genetics, anatomy and function of enteric neural serotonergic pathways in inbred mice. J Physiol 2009; 587: 567-586.
6. Zill P, Buttner A, Eisenmenger W, Bondy B, Ackenheil M. Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 2004; 14: 282-284. (Pubitemid 38649084)
7. Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res 2006; 1085: 11-18. (Pubitemid 43728204)
8. Alenina N, Kikic D, Todiras M, Mosienko V, Qadri F, Plehm R et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci USA 2009; 106: 10332-10337.
9. Liu Y, Jiang Y, Si Y, Kim JY, Chen ZF, Rao Y. Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. Nature 2011; 472: 95-99.
10. Savelieva KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E et al. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 2008; 3: e3301.
11. Thomas DM, Angoa Perez M, Francescutti-Verbeem DM, Shah MM, Kuhn DM. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum. J Neurochem 2010; 115: 595-605.
12. Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009; 138: 976-989.
13. Levinson DF. The genetics of depression: a review. Biol Psychiatry 2006; 60: 84-92.
14. Lohoff FW. Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 2010; 12: 539-546.
15. Matthes S, Mosienko V, Bashammakh S, Alenina N, Bader M. Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology 2010; 85: 95-109.
16. Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback KF, Adolfsson R et al. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry 2006; 63: 1103-1110. (Pubitemid 44498389)
17. Zill P, Baghai TC, Zwanzger P, Schule C, Eser D, Rupprecht R et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 2004; 9: 1030-1036. (Pubitemid 39524291)
18. Hovatta I, Barlow C. Molecular genetics of anxiety in mice and men. Ann Med 2008; 40: 92-109. (Pubitemid 351640644)
19. Craig IW, Halton KE. Genetics of human aggressive behaviour. Hum Genet 2009; 126: 101-113.
20. Zalsman G, Patya M, Frisch A, Ofek H, Schapir L, Blum I et al. Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center study. World J Biol Psychiatry 2011; 12: 33-41.
21. Gibbons RD, Davis JM. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels. Acta Psychiatr Scand 1986; 74: 8-12. (Pubitemid 16061280)
22. Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 2001; 50: 783-791. (Pubitemid 33086766)
23. Stanley M, Traskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 1985; 37: 1279-1286. (Pubitemid 15013197)
24. Birger M, Swartz M, Cohen D, Alesh Y, Grishpan C, Kotelr M. Aggression: the testosterone-serotonin link. Isr Med Assoc J 2003; 5: 653-658. (Pubitemid 37203536)
25. Brown GL, Linnoila MI. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry 1990; 51Suppl: 31-41, discussion 42-33. (Pubitemid 20134805)
26. Stanley B, Molcho A, Stanley M, Winchel R, Gameroff MJ, Parsons B et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry 2000; 157: 609-614. (Pubitemid 30191201)
27. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167. (Pubitemid 16239568)
28. Njung'e K, Handley SL. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 1991; 38: 63-67.
29. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH et al. Altered depressionrelated behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 2003; 54: 960-971. (Pubitemid 37415032)
30. Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ, Palha JA et al. A transdimensional approach to the behavioral aspects of depression. Front Behav Neurosci 2009; 3: 1.
31. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336. (Pubitemid 8225714)
32. Kulikov AV, Osipova DV, Naumenko VS, Popova NK. Association between Tph2 gene polymorphism, brain tryptophan hydroxylase activity and aggressiveness in mouse strains. Genes Brain Behav 2005; 4: 482-485. (Pubitemid 41689393)
33. Yamaguchi T, Sawada M, Kato T, Nagatsu T. Demonstration of tryptophan 5- monooxygenase activity in human brain by high sensitive high-performance liquid chromatography with fluorometric detection. Biochem Int 1981; 2: 295-303. (Pubitemid 11121503)
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
35. Brodie BB, Pletscher A, Shore PA. Evidence that serotonin has a role in brain function. Science 1955; 122: 968.
36. Lopez-Munoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des 2009; 15: 1563-1586.
37. Price LH, Malison RT, McDougle CJ, Pelton GH, Heninger GR. The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biol Psychiatry 1998; 43: 339-347. (Pubitemid 28137626)
38. van Praag HM. In search of the mode of action of antidepressants. 5-HTP/tyrosine mixtures in depressions. Neuropharmacology 1983; 22: 433-440. (Pubitemid 13152055)
39. Miller HL, Delgado PL, Salomon RM, Licinio J, Barr LC, Charney DS. Acute tryptophan depletion: a method of studying antidepressant action. J Clin Psychiatry 1992; 53 Suppl: 28-35.
40. Schruers K, Griez E. The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 2003; 74: 305.
41. Baker M. Animal models: inside the minds of mice and men. Nature 2011; 475: 123-128.
42. Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004; 9: 326-357. (Pubitemid 38534696)
43. Drugan RC, Morrow AL, Weizman R, Weizman A, Deutsch SI, Crawley JN et al. Stressinduced behavioral depression in the rat is associated with a decrease in GABA receptormediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res 1989; 87: 45-51. (Pubitemid 19135164)
44. O'Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. Eur Neuropsychopharmacol 2007; 17: 215-226. (Pubitemid 44779196)
45. Fukui M, Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci 2007; 27: 10520-10529. (Pubitemid 47502010)
46. Narboux-Neme N, Sagne C, Doly S, Diaz SL, Martin CB, Angenard G et al. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology 2011.
47. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005; 4: 775-790. (Pubitemid 43090498)
48. Bai F, Li X, Clay M, Lindstrom T, Skolnick P. Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 2001; 70: 187-192. (Pubitemid 33049928)
49. Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC et al. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 2008; 105: 1333-1338. (Pubitemid 351397053)
50. Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S et al. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 547-553. (Pubitemid 38823986)
51. O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 2007; 192: 357-371. (Pubitemid 46701581)
52. Redrobe JP, Bourin M. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology 1998; 138: 198-206. (Pubitemid 28330838)
53. Vataeva LA, Kudrin VS, Vershinina EA, Mosin VM, Tiul'kova EI, Otellin VA. Behavioral alteration in the adult rats prenatally exposed to para-chlorophenylalanine. Brain Res 2007; 1169: 9-16. (Pubitemid 47381353)
54. Vataeva LA, Kudrin VS, Vershinina EA, Mosin VM, Tiul'kova EI, Otellin VA. Maternal parachlorophenylalanine exposure modifies central monoamines and behaviors in the adult offspring. Brain Res 2008; 1234: 1-7.
55. Maas JW. Neurochemical differences between two strains of mice. Science 1962; 137: 621-622.
56. Valzelli L, Giacalone E, Garattini S. Pharmacological control of aggressive behavior in mice. Eur J Pharmacol 1967; 2: 144-146.
57. Coccaro EF. Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int Clin Psychopharmacol 1992; 7: 3-12.
58. Coccaro EF, Kavoussi RJ, Hauger RL. Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biol Psychiatry 1997; 42: 546-552. (Pubitemid 27425472)
59. Zajicek KB, Price CS, Shoaf SE, Mehlman PT, Suomi SJ, Linnoila M et al. Seasonal variation in CSF 5-HIAA concentrations in male rhesus macaques. Neuropsychopharmacology 2000; 22: 240-250. (Pubitemid 30089534)
60. Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F. Serotonergic functioning and trait-impulsivity in attention-deficit/ hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion. Hum Psychopharmacol 2008; 23: 43-51. (Pubitemid 351166067)
61. Nantel-Vivier A, Pihl RO, Young SN, Parent S, Belanger SA, Sutton R et al. Serotonergic contribution to boys' behavioral regulation. PLoS One 2011; 6: e20304.
62. Schaefer TL, Vorhees CV, Williams MT. Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. Neuroscience 2009; 164: 1431-1443.
63. Heinz AJ, Beck A, Meyer-Lindenberg A, Sterzer P, Heinz A. Cognitive and neurobiological mechanisms of alcohol-related aggression. Nat Rev Neurosci 2011; 12: 400-413.
64. Ferrari PF, van Erp AM, Tornatzky W, Miczek KA. Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 2003; 17: 371-378. (Pubitemid 36459517)
65. van Erp AM, Miczek KA. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci 2000; 20: 9320-9325. (Pubitemid 32042936)
66. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151-162. (Pubitemid 28378297)
67. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003; 37: 233-247. (Pubitemid 36143819)
68. Wise CD, Berger BD, Stein L. Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 1972; 177: 180-183.
69. Andrade TG, Macedo CE, Zangrossi Jr H, Graeff FG. Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze. Behav Brain Res 2004; 153: 55-60. (Pubitemid 38829288)
70. Briley M, Chopin P, Moret C. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology 1990; 101: 187-189. (Pubitemid 20140216)
71. Critchley MA, Njung'e K, Handley SL. Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology 1992; 106: 484-490.
72. Soderpalm B, Engel JA. Serotonergic involvement in conflict behaviour. Eur Neuropsychopharmacol 1990; 1: 7-13.
73. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004; 306: 879-881. (Pubitemid 39446998)
74. Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2003; 2: 365-380. (Pubitemid 37463201)
75. Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA et al. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 2006; 26: 8955-8964. (Pubitemid 44319384)
76. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002; 416: 396-400. (Pubitemid 34272867)
77. Dai JX, Han HL, Tian M, Cao J, Xiu JB, Song NN et al. Enhanced contextual fear memory in central serotonin-deficient mice. Proc Natl Acad Sci USA 2008; 105: 11981-11986.
78. Kiyasova V, Fernandez SP, Laine J, Stankovski L, Muzerelle A, Doly S et al. A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. J Neurosci 2011; 31: 2756-2768.
79. Zhao S, Edwards J, Carroll J, Wiedholz L, Millstein RA, Jaing C et al. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotionrelated behaviors in mice. Neuroscience 2006; 140: 321-334. (Pubitemid 43668455)
80. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB et al. Lossof- function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005; 45: 11-16. (Pubitemid 40075345)
81. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 1971; 173: 149-152.
82. Markus CR. Dietary amino acids and brain serotonin function; implications for stressrelated affective changes. Neuromolecular Med 2008; 10: 247-258.
83. Siesser WB, Zhang X, Jacobsen JP, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice. Neurosci Lett 2010; 481: 6-11.
84. Tenner K, Qadri F, Bert B, Voigt JP, Bader M. The mTPH2 C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains. Neurosci Lett 2008; 431: 21-25.